Sotera Health (SHC) financial statements
Sotera Health reported revenue of $1.2B in fiscal 2025, up 6.9% a year over 6 years.
Net income was $78M.
Free cash flow was $149M.
The diluted share count rose 23% over the period (dilution).
Revenue and free cash flow
Fiscal years, $ billions.
Income statement
Fiscal years, from Sotera Health's 10-K filings with the SEC.
| Fiscal year | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | $778M | $818M | $931M | $1.0B | $1.0B | $1.1B | $1.2B |
| Cost of revenue | $383M | $375M | $413M | $447M | $472M | $498M | $518M |
| Gross profit | $395M | $444M | $519M | $557M | $577M | $602M | $646M |
| Selling, general and admin | $147M | $179M | $198M | $246M | $237M | $243M | $253M |
| Operating income | $184M | $206M | $257M | $248M | $277M | $298M | — |
| Pre-tax income | -$916,000 | -$39M | $176M | -$243M | $106M | $114M | $148M |
| Income tax | $20M | -$1M | $59M | -$10M | $55M | $69M | $70M |
| Net income | -$21M | -$39M | $117M | -$234M | $51M | $44M | $78M |
| EPS (diluted) | -$0.09 | -$0.16 | $0.41 | -$0.83 | $0.18 | $0.16 | $0.27 |
| Diluted shares | 232M | 238M | 279M | 280M | 283M | 285M | 286M |
| Gross margin | 50.8% | 54.2% | 55.7% | 55.5% | 55.0% | 54.7% | 55.5% |
| Operating margin | 23.6% | 25.2% | 27.6% | 24.7% | 26.4% | 27.0% | — |
| Net margin | -2.7% | -4.7% | 12.5% | -23.3% | 4.9% | 4.0% | 6.7% |
Balance sheet
Fiscal years, from Sotera Health's 10-K filings with the SEC.
| Fiscal year | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Cash and short-term investments | $63M | $102M | $107M | $395M | $296M | $277M | $345M |
| Receivables | — | $92M | $108M | $118M | $148M | $140M | $139M |
| Inventory | — | $34M | $54M | $37M | $48M | $49M | $54M |
| Total current assets | — | $315M | $346M | $645M | $557M | $526M | $613M |
| Property, plant and equipment | — | $610M | $651M | $775M | $947M | $1.0B | $1.1B |
| Goodwill | $1.0B | $1.1B | $1.1B | $1.1B | $1.1B | $1.1B | $1.1B |
| Total assets | — | $2.8B | $2.8B | $3.1B | $3.1B | $3.1B | $3.3B |
| Total current liabilities | — | $141M | $161M | $792M | $231M | $191M | $250M |
| Long-term debt | — | $1.8B | $1.7B | $1.7B | $2.2B | $2.2B | $2.1B |
| Total liabilities | — | $2.3B | $2.2B | $2.8B | $2.7B | $2.7B | $2.7B |
| Shareholders' equity | -$641M | $452M | $586M | $350M | $444M | $405M | $606M |
| Net debt | -$63M | $1.7B | $1.6B | $1.5B | $1.9B | $1.9B | $1.8B |
Cash flow
Fiscal years, from Sotera Health's 10-K filings with the SEC.
| Fiscal year | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $149M | $121M | $282M | $278M | -$148M | $224M | $287M |
| Capital spending | $57M | $54M | $102M | $182M | $215M | $179M | $138M |
| Free cash flow | $92M | $67M | $179M | $96M | -$363M | $45M | $149M |
| Stock-based compensation | $7M | $11M | $14M | $21M | $32M | $37M | $31M |
| Dividends paid | $691M | $0 | $0 | — | — | — | — |
| Share buybacks (net) | $0 | -$34M | $0 | $0 | — | — | — |
| Net borrowing | $584M | -$1.0B | -$100M | $200M | $498M | -$5M | -$86M |
| Free cash flow margin | 11.8% | 8.2% | 19.3% | 9.5% | -34.6% | 4.1% | 12.8% |
| Dividends per share | $2.97 | — | — | — | — | — | — |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for SHC.
Open SHC in InvestinglyQuestions
What was Sotera Health's revenue in 2025?
$1.2B in fiscal 2025, from its 10-K filing.
How much free cash flow does Sotera Health generate?
$149M in fiscal 2025 (operating cash flow minus capital spending).
From Sotera Health's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.